Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 10, 2026 · Leadership change · Item 5.07
Metagenomi Therapeutics, Inc.
4
Leadership change
Jun 10, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.07 | Item 5.07 |
Metagenomi Therapeutics, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
) 5959 Horton Street 7th Floor Emeryville , California 94608 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (510) 871-4880 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting mate…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Metagenomi Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
